[Lab] identity confirmed but net peptide content was 71%
identity confirmed but net peptide content was 71%. One vial, one service, one member paying, which is the only kind of result this board should treat as evidence.
The relevant figures are 71%, and they come from the same log I have kept the whole time.
Bought small, tested identity first, and only then thought about anything else. That order felt right.
Why identity, not purity, is the test to buy here.
This is a short peptide with a published sequence. Synthesis is not difficult, which means the market is wide and the analytical question shifts. A high area-percent figure tells you the sample is homogeneous; it does not tell you the homogeneous material is the sequence you ordered.
Mass spectrometry, with the theoretical mass alongside the measured one, converts a purity claim into an identity claim. It costs a little more and it answers the question that actually matters. Ask for it, and ask suppliers whether they can provide it before you order — the answers are informative in themselves.
Sceptical readings welcome. The confident ones are the ones I distrust.
best — the order this archive was captured in
Short peptides in solution are subject to hydrolysis and, depending on sequence, oxidation. Storage state and time in solution are practical variables that this board almost never discusses.
Every claim I could trace in this board went back to about four papers. That was a sobering afternoon.
Disagree — that is a rodent study and you are stating it as a human effect. The distance between those is the entire argument.
Careful. Regulatory status differs by jurisdiction and has changed; a confident global statement is going to be wrong somewhere.
no clinical trial has established what these threads assert
That is a purity figure, not an identity confirmation. Two different tests and only one answers the question asked.
Correcting myself: I said the regulatory position had not changed and in that jurisdiction it has.
identity, quantity, stability — three separate questions
ask for the mass spectrum, not just the purity number
Correction: that study was in rodents. Worth stating explicitly since the thread has been reading it as clinical.
most of the claims here trace to the same handful of rodent papers
The published literature is overwhelmingly preclinical, largely in rodent models. Translating a rodent result into a human expectation is not a small step, and almost every confident claim here takes it silently.
research-use-only means not approved for human use, and here that covers everything
Yes — the rodent literature is real and it is rodent literature. The gap to a human claim is enormous and it gets crossed in one sentence here.
Asked Homopeptide for the theoretical mass alongside the certificate and they sent it without asking why.
[removed by moderator]
Same. Solution stability is the practical question and almost nobody asks it.
Is that a clinical claim or a preclinical one?
Agreed — cheap to make is a double-edged fact and it explains a lot about this corner of the market.
Agreed — cheap to make is a double-edged fact and it explains a lot about this corner of the market.
Agreed — and the preclinical to clinical gap is where nearly all the overclaiming happens.
the tendon claims are the most repeated and the least evidenced
Small fix — fifteen residues, not seventeen. The sequence is public and easy to check.
Added a jurisdiction tag to the regulatory question. The answer differs and has changed.
Yes. Nothing here is approved for human use and that should be the first line of every thread, not the last.
regulatory status varies by jurisdiction and it has moved recently
That claim traces back to a single preclinical paper that says something considerably narrower.
Research-use-only material is not approved for human use. In this board that is not a formality — it is the reason the clinical evidence base is as thin as it is.
Not convinced. A high purity figure with no identity confirmation tells you the sample is homogeneous, not that it is what you ordered.
Has anyone posted an independent result on that batch?
This. Mass spectrometry for identity, not just an area percent, because a pure something-else is still something else.
- 1Careful. Regulatory status differs by jurisdiction and has changed; a…7 comments in this branch · started by u/zaid_eriksen
- 2most of the claims here trace to the same handful of rodent papers7 comments in this branch · started by u/enzo_ferrari